AAM calls for policies in the US that encourage greater use of biosimilars.

Why organ-on-chip technology could transform drug discovery and development.

Schott explains how ready-to-use containers can improve total costs of ownership for pharma companies.

How can pharma use synthetic data to enhance clinical trials?

Is there a place for traditional medicines in the pharmaceutical industry?

New guidance on the use of whey and lactose-derived products in pharmaceuticals.

We interview Johannes Khinast, CEO and Scientific Director of the Research Center for Pharmaceutical Engineering (RCPE), Graz, Austria.

How has COVID-19 affected the pharma industry and medicine makers across the world?

Fake COVID-19 treatments and vaccines are abound – but the FDA is on the case.

We need to open our eyes to the realities of sleep disorders.